Enhanced cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor.

被引：0

作者：

Mizutani, Yoichi ^{[1
]}

Li, Yong Nan ^{[1
]}

Shiraishi, Takumi ^{[1
]}

Nakamura, Terukazu ^{[1
]}

Nomoto, Takeshi ^{[1
]}

Okihara, Koji ^{[1
]}

Ukimura, Osamu ^{[1
]}

Yoneda, Kimihiko ^{[1
]}

Kawauchi, Akihiro ^{[1
]}

Miki, Tsuneharu ^{[1
]}

机构：

[1] Kyoto Prefectural Univ Med, Kyoto, Japan

来源：

CANCER RESEARCH | 2006年 / 66卷 / 08期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

5419

引用

页数：2

共 50 条

[1] Enhancement of cisplatin-mediated cytotoxicity and apoptosis against bladder cancer cells in vitro and in vivo by the selective cyclooxygenase-2 inhibitor
Mizutani, Y
Li, YN
Shiraishi, T
Nakamura, T
Nomoto, T
Okihara, K
Ukimura, O
Yoneda, K
Kawauchi, A
Miki, T
JOURNAL OF UROLOGY, 2006, 175 (04): : 207 - 208
[2] Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522
Mizutani, Y
Nakanishi, H
Li, YN
Sato, N
Kawauchi, A
Miki, T
JOURNAL OF UROLOGY, 2004, 172 (04): : 1474 - 1479
[3] Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, and 5-fluorouracil against bladder cancer
Mizutani, Y
Kamoi, K
Ukimura, O
Kawauchi, A
Miki, T
JOURNAL OF UROLOGY, 2002, 168 (06): : 2650 - 2654
[4] Effects of a selective cyclooxygenase-2 inhibitor on cancer cells in vitro
Fife, RS
Stott, B
Carr, RE
CANCER BIOLOGY & THERAPY, 2004, 3 (02) : 228 - 232
[5] Synergistic cytotoxicity and apoptosis of JTE-522, a selective cyclooxygenase-2 inhibitor, in combination with 5-fluorouracil against bladder cancer
Mizutani, Y
Nakanishi, H
Li, Y
Matsubara, H
Nomoto, T
Nakao, M
Miki, T
JOURNAL OF UROLOGY, 2003, 169 (04): : 137 - 137
[6] Combination chemotherapy with JTE-522, a novel selective cyclooxygenase-2 inhibitor, and cisplatin against gastric cancer cell lines in vitro and in vivo
Sugiura, T
Saikawa, Y
Kubota, T
Suganuma, K
Otani, Y
Watanabe, M
Kumai, K
Kitajima, M
IN VIVO, 2003, 17 (03): : 229 - 233
[7] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Zhi-Jun Dai
Xiao-Bin Ma
Hua-Feng Kang
Jie Gao
Wei-Li Min
Hai-Tao Guan
Yan Diao
Wang-Feng Lu
Xi-Jing Wang
Cancer Cell International, 12
[8] Antitumor activity of the selective cyclooxygenase-2 inhibitor, celecoxib, on breast cancer in Vitro and in Vivo
Dai, Zhi-Jun
Ma, Xiao-Bin
Kang, Hua-Feng
Gao, Jie
Min, Wei-Li
Guan, Hai-Tao
Diao, Yan
Lu, Wang-Feng
Wang, Xi-Jing
CANCER CELL INTERNATIONAL, 2012, 12
[9] A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2
Pyo, H
Choy, H
Amorino, GP
Kim, JS
Cao, QW
Hercules, SK
DuBois, RN
CLINICAL CANCER RESEARCH, 2001, 7 (10) : 2998 - 3005
[10] The bromodomain inhibitor JQ1 enhances cisplatin-mediated cytotoxicity in ovarian cancer cells
Khabele, Dineo
Wilson, Andrew J.
Saskowski, Jeanette
Hiebert, Scott W.
CLINICAL CANCER RESEARCH, 2013, 19

← 1 2 3 4 5 →